Chemomab Therapeutics Ltd. American Depositary Share CMMB
$2.69
-2.18%
at last close
Market Cap$20.15 million
P/E Ratio—
Div Yield—
Volume76.6K
52-Week Range
$1.35$4.12
Key Stats
- Today's Range
- $2.59 – $2.80
- 50-Day Range
- $1.36 – $2.99
- 52-Week Range
- $1.35 – $4.12
- Volume
- 77K shs
- Average Volume
- 100K shs
- Market Cap
- $20.15 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.17%
- Days to Cover
- 1.00
About Chemomab Therapeutics Ltd. American Depositary Share
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Related Stocks
Compare head-to-head: CMMB vs LLY·CMMB vs JNJ·CMMB vs ABBV·CMMB vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.